Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CATB - Catabasis' Catastrophic Failure And Other News: The Good Bad And Ugly Of Biopharma

CATB - Catabasis' Catastrophic Failure And Other News: The Good Bad And Ugly Of Biopharma

Catabasis Pharmaceuticals Inc.
  • Catabasis failed a Phase 3 Duchenne Muscular Dystrophy trial.
  • Revolution Medicines reports anti-tumor activity for RMC-4630.
  • Novartis reports positive data for iptacopan in C3 glomerulopathy.

For further details see:

Catabasis' Catastrophic Failure, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Catabasis Pharmaceuticals Inc.
Stock Symbol: CATB
Market: NASDAQ
Website: catabasis.com
Menu
CATB CATB Quote CATB Short CATB News CATB Articles CATB Message Board
Get CATB Alerts

News, Short Squeeze, Breakout and More Instantly...